Research output per year
Research output per year
Personal profile
Expertises
Multiple sclerosis, neuroimmunology; clinical trials
Main research areas
Core elements of research: Studies of the cerebrospinal fluid including: Studies of vasopressin in the human cerebrospinal fluid (thesis 1986); neurooncology; neuroimmunology; multiple sclerosis including clinical trials, development of new therapies, clinical- translational- and biomarker-research.
Current research
Clinical trials in multiple sclerosis, epidemiology of multiple sclerosis
External positions
University of Copenhagen
2005 → …
Fingerprint
Dive into the research topics where Per Soelberg Sørensen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Disease-modifying treatment and disability progression in subclasses of patients with primary progressive MS: results from the Big MS Data Network
Lorscheider, J., Signori, A., Subramaniam, S., Benkert, P., Vukusic, S., Trojano, M., Hillert, J., Glaser, A., Hyde, R., Spelman, T., Magyari, M., Elberling, F., Pontieri, L., Koch-Henriksen, N., Sørensen, P. S., Gerlach, O., Prat, A., Girard, M., Eichau, S. & Grammond, P. & 23 others, , 14 May 2025, In: Journal of neurology, neurosurgery, and psychiatry. 96, 6, p. 606-615 10 p., 334700.Research output: Contribution to journal › Journal article › Research › peer-review
-
Patient-Generated Data as Indicators of Impact of Multidisciplinary and Multi-stakeholder Health Care Systems, in the Age of Personalised Medicine
Zaratin, P., Soelberg Sørensen, P., Fernández, Ó. & Comi, G., Apr 2025, In: Neurology and therapy. 14, 2, p. 437-446 10 p., e530.Research output: Contribution to journal › Comment/debate › Research › peer-review
1 Citation (Scopus) -
Should natalizumab be used despite JC virus positivity? No
Dalla Costa, G., Magyari, M. & Sorensen, P. S., 30 May 2025, (E-pub ahead of print) In: Multiple Sclerosis Journal. p. 13524585251346382 13524585251346382.Research output: Contribution to journal › Journal article › Research › peer-review
-
Subcortical plaques and inflammation reflect cortical and meningeal pathologies in progressive multiple sclerosis
Okutan, B., Frederiksen, J. L., Houen, G., Sellebjerg, F., Kyllesbech, C., Magyari, M., Paunovic, M., Sørensen, P. S., Jacobsen, C., Lassmann, H. & Bramow, S., May 2025, In: Brain pathology (Zurich, Switzerland). 35, 3, p. e13314 e13314.Research output: Contribution to journal › Journal article › Research › peer-review
2 Citations (Scopus) -
Age-corrected neurofilament light chain ratio decreases but does not predict relapse in highly active multiple sclerosis patients initiating natalizumab treatment
Højsgaard Chow, H., Petersen, E. R., Olsson, A., Hejgaard Laursen, J., Bredahl Hansen, M., Oturai, A. B., Soelberg Sørensen, P., Bach Søndergaard, H. & Sellebjerg, F., Aug 2024, In: Multiple Sclerosis and Related Disorders. 88, 105701.Research output: Contribution to journal › Journal article › Research › peer-review
2 Citations (Scopus)